Estrogen replacement therapy and cognitive decline in memory-impaired post-menopausal women

Biological Psychiatry

Volumn 46, Issue 2, 1999, Pages 182-188

  Costa, M Martin ^a   Reus, Victor I ^a   Wolkowitz, Owen M ^a   Manfredi, Francesca ^a   Lieberman, Morton ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alzheimer's dementia; Cognitive impairment; Estrogen replacement therapy; Memory

Indexed keywords

ESTROGEN;

ADULT; ALZHEIMER DISEASE; AMNESIA; ARTICLE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DEMENTIA; DRUG EFFICACY; ESTROGEN THERAPY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MEMORY; POSTMENOPAUSE; PRIORITY JOURNAL;

AGED; COGNITION; COGNITION DISORDERS; ESTRADIOL; FEMALE; FOLLOW-UP STUDIES; HORMONE REPLACEMENT THERAPY; HUMANS; MEMORY; MEMORY DISORDERS; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; POSTMENOPAUSE; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 0032989956     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(98)00355-2     Document Type: Article

References (30)

1. Asthana S., Craft S., Baker L.D., et al. Transdermal estrogen improves memory in women with Alzheimer's disease. Soc Neurosci Abstr. 22:1996;200.
2. Barrett-Connor E., Kritz-Silverstein D. Estrogen replacement therapy and cognitive function in older women. JAMA. 269:1993;2637-2641.
3. Birge S.J. Is there a role for estrogen replacement therapy in the prevention and treatment of dementia? J Am Geriatr Soc. 44:(7):1996;865-870.
4. Blessed G, Tomlinson BE, Roth M (1968): The association between quantitative measures of dementia and of senile changes in the cerebral grey matter of elderly subjects. Br J Psychiatry 114:797-711.
5. Brenner D.E., Kukull W.A., Stergachis A., et al. Postmenopausal estrogen replacement therapy and the risk of Alzheimer's disease A population-based case-control study . Am J Epidemiol. 140:(3):1994;262-267.
6. Buckwalter J., Sobel E., Dunn M., Diz M., Henderson V. Gender differences on a brief measure of cognitive functioning in Alzheimer's disease. Arch Neurol. 50:1993;757-760.
7. Fillet H. Estrogens in the pathogenesis and treatment of Alzheimer's disease. Ann N Y Acad Sci. 743:1994;233-238.
8. Fillit H., Weinreb H., Cholst I., et al. Observations in a preliminary open trial of estradiol therapy for senile dementia-Alzheimer's type. Psychoneuroendocrinology. 11:1986;337-345.
9. Giannakopolos P., Hof P., Mottier S., Michel J., Bouras C. Neuropathological changes in the cerebral cortex of 1258 cases from a geriatric hospital Retrospective clinicopathological evaluation of a 10-year autopsy population . Acta Neuropathol. 87:(5):1994;456-468.
10. Gibbs RB (1994): Estrogen and nerve growth factor-related systems in brain. Effects on basal forebrain cholinergic neurons and implications for learning and memory processes and aging. Ann N Y Acad Sci 743:165-196; discussion 197-199.
11. Haskell S.G., Richardson E.D., Horwitz R.I. The effect of estrogen replacement therapy on cognitive function in women A critical review of the literature . J Clin Epidemiol. 50:(11):1997;1249-1264.
12. Henderson V.W., Watt L., Buckwalter J. Cognitive skills associated with estrogen replacement in women with Alzheimer's disease. Psychoneuroendocrinology. 21:1996;421-430.
13. Honjo Y., Ogino Y., Naitoh K., et al. In vivo effects by estrone sulfate on the central nervous system senile dementia (Alzheimer's type). J Steroid Biochem Mol Biol. 34:1989;521-525.
14. Kampen D.L., Sherwin B.B. Estrogen use and verbal memory in healthy postmenopausal women. Obstet Gynecol. 83:1994;979-983.
15. Kawas C., Resnick S., Morrison A., et al. A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease The Baltimore Longitudinal Study of Aging . Neurology. 48:1997;1517-1521.
16. Lewis C., McEwen B.S., Frankfurt M. Estrogen-induction of dendritic spines in ventromedial hypothalamus and hippocampus Effects of neonatal aromatase blockade and adult GDX . Brain Res Dev Brain Res. 87:1995;91-95.
17. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E. Clinical diagnosis of Alzheimer's disease Report of the NINCDS-ADRA work group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's disease . Neurology. 34:1984;939-944.
18. Mortel K.F., Meyer J.S. Lack of postmenopausal estrogen replacement therapy and the risk of dementia. J Neuropsychiatry Clin Neurosci. 7:(3):1995;334-337.
19. Ohkura T., Isse K., Akazawa K., Hamamoto M., Yaoi Y., Hagino N. Evaluation of estrogen treatment in female patients with dementia of the Alzheimer's type. Endocr J. 41:1994;361-371.
20. Paganini-Hill A., Buckwalter J.G., Logan C.G., Henderson V.W. Estrogen replacement and Alzheimer's disease in women. Soc Neurosci Abstr. 19:1993;1046.
21. Paganini-Hill A., Henderson V.W. Estrogen deficiency and risk of Alzheimer's disease in women. Am J Epidemiol. 140:1994;256-261.
22. Phillips S.M., Sherwin B.B. Effects of estrogen on memory function in surgically menopausal women. Psychoneuroendocrinology. 17:1992;485-495.
23. Phillips S.M., Sherwin B.B. Variations in memory func-tion and sex steroid hormones across the menstrual cycle. Psychoneuroendocrinology. 17:1992;497-506.
24. Resnick S.M., Metter E.J., Zonderman A.B. Estrogen replacement therapy and longitudinal decline in visual memory. A possible protective effect? Neurology. 49:(6):1997;1491-1497.
25. Schneider L.S., Farlow M.R., Henderson V.W., Pogoda J.M. Effects of estrogen replacement therapy on response to tacrine in patients with Alzheimer's disease. Neurology. 46:1996;1580-1584.
26. Sherwin BB (1994): Estrogenic effects on memory in women. Ann N Y Acad Sci 743:213-230; discussion 230-231.
27. Sultzer D.L., Cummings J.L. Secondary dementias in aging. Albert M.L., Knoffel J.E. Clinical Neurology of Aging. 1994;391 Oxford University Press, New York.
28. Tang M.X., Jacobs D., Stern Y., et al. Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet. 348:1996;429-432.
29. Woolley C.S., McEwen B.S. Roles of estradiol and progesterone in regulation of hippocampal dendritic spine density during the estrous cycle in the rat. Journal of Comparative Neurology. 336:1993;293-306.
30. Woolley C.S., McEwen B.S. Estradiol regulates hippocampal dendritic spine density via an N-methyl-D-aspartate receptor-dependent mechanism. Journal of Neuroscience. 14:1994;7680-7687.